An Open-Label Extension Study of BPN14770 in Subjects With Fragile X Syndrome
Status:
Not yet recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
This is an open-label extension (OLE) study for subjects completing one of two double-blind
clinical trials with BPN14770, Study BPN14770-CNS-301(in adult males) and Study
BPN14770-CNS-204 (in adolescent males).